Currently, treatment with a specific anti-epileptic drug mainly depends on the physicians'
preference, as there are no studies supporting the use of one specific anticonvulsant in
glioma patients. The overall aim of this randomized controlled trial is to directly compare
the effectiveness of treatment with levetiracetam or valproic acid in glioma patients with a
first seizure.
Phase:
Phase 4
Details
Lead Sponsor:
Leiden University Medical Center
Collaborators:
Erasmus Medical Center Medical Center Haaglanden VU University Medical Center